From Assembly Lines to AI-Driven Drug Discovery: Crystal Brown's CircNova Pioneers a New Era in Biotech
Discover how automotive executive Crystal Brown pivoted to biotech, founding CircNova with AI-driven circular RNA drug discovery.
Matilda
From Assembly Lines to AI-Driven Drug Discovery: Crystal Brown's CircNova Pioneers a New Era in Biotech
In the heart of Michigan's burgeoning tech scene, a quiet revolution is taking place, led by a woman whose journey defies conventional expectations. Crystal Brown, a former automotive executive, has traded the assembly line for the intricate world of biotechnology, founding CircNova, a startup poised to redefine drug discovery with its AI-powered approach to circular RNA. This groundbreaking venture has secured a $3.3 million seed funding round, a testament to Brown's vision and the transformative potential of CircNova's technology. A Serendipitous Leap into Biotech Crystal Brown's path to biotech leadership was anything but linear. For years, she honed her skills in the demanding automotive manufacturing industry, climbing the corporate ladder with aspirations of reaching the C-suite. However, a chance encounter with a life science startup CEO sparked a profound curiosity. Initially offering her expertise on a part-time basis, Brown quickly found herself immersed in the…
